Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 17.667\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CC(Sc1nc(N)cc(=O)[nH]1)C(=O)Nc1sc2c(c1C#N)CCCC2
b: Cc1nn(C(C)C(=O)N2CCN(c3ccccn3)CC2)c(=O)c2cc3occc3n12
Answer: a. CC(Sc1nc(N)cc(=O)[nH]1)C(=O)Nc1sc2c(c1C#N)CCCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(Sc1nc(N)cc(=O)[nH]1)C(=O)Nc1sc2c(c1C#N)CCCC2
CC(Sc1nc(N)cc(=O)[nH]1)C(=O)Nc1sc2c(c1C#N)CCCC2
2-[(4-amino-6-oxo-1H-pyrimidin-2-yl)sulfanyl]-N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)propanamide